These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Author: Nasrallah HA, Dunner FJ, McCalley-Whitters M, Smith RE.
    Journal: J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037.
    Abstract:
    Despite the plethora of clinical drug trials in tardive dyskinesia, few consistent findings have emerged. One possible reason for this is that there have been no serious attempts to define the role of major neurotransmitter systems (dopamine, norepinephrine, acetylcholine, serotonin, GABA) in one specific population of tardive dyskinesia patients. This study reports a series of five controlled drug trials in a population of patients with persistent tardive dyskinesia; each drug probed one of four neurotransmitter systems. The intra- and interpatient responses are analyzed and the implications of the pharmacologic response profiles for the clinical management of tardive dyskinesia are discussed.
    [Abstract] [Full Text] [Related] [New Search]